Search

Current filters: Pregnancy, Reproductive and maternal health

CATIE statement on the use of antiretroviral treatment (ART) to maintain an undetectable viral load as a highly effective strategy to prevent perinatal transmission of HIV

2020, CATIE
Research summary - Webpage

Growing Your Family

2020, CATIE
Brochure - Webpage

Decreasing the risk of neural tube defects with dolutegravir

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Having an HIV-Negative Baby

From The Power of Undetectable: What you need to know about HIV treatment as prevention
2019, CATIE
Client resources - Webpage

HIV in pregnancy: Identification of intrapartum and perinatal HIV exposures

2019, Canadian Pediatric Society
Webpage
More info

HIV transmission through breastfeeding

2019, Ontario HIV Treatment Network (OHTN)
Video - Video
More info

FDA warns that Prezcobix should not be used by HIV-positive pregnant women

From TreatmentUpdate 228
2018, CATIE
Research summary - Webpage

PrEP for understudied populations: Exploring questions about efficacy and safety

From Prevention in Focus - Fall 2018
2018, CATIE
Research summary - Webpage

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women

2018, CATIE
Research summary - Webpage

Researchers study the impact of co-infection with hepatitis viruses on pregnant women with HIV

2018, CATIE
Research summary - Webpage